BioPharma Credit grows capital raising to $305m
BioPharma Credit, the UK closed-end investment fund that provides debt funding to the life sciences industry, has priced its latest capital raise, growing the deal to $305m.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts